Effect of TECAR on Cervical Radiculopathy

NCT07289607 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-12-18

No results posted yet for this study

Summary

Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control.

TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.

Conditions

  • Cervical Radiculopathy

Interventions

DEVICE

TECAR therapy

TECAR Therapy A form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.

DEVICE

Sham TECAR therapy

TECAR Therapy a form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.

Sponsors & Collaborators

  • Delta University for Science and Technology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-03-05
Completion
2026-04-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07289607 on ClinicalTrials.gov